Apr 19, 2025, 22:44

The Children’s Cancer Foundation (CCF) Giant Food NextGen Award

The Children’s Cancer Foundation (CCF) Giant Food NextGen Award supports early-career pediatric oncology investigators in the Maryland/DC/Northern Virginia region. Designed to fund promising researchers at the beginning of their independent careers, this grant helps launch impactful research focused on improving pediatric cancer treatment and outcomes. The award is made possible through the generous support of Giant Food.

Eligibility Criteria

MD, PhD, DO, MBBS, MSN-NP or equivalent degree
Completed Pediatric Oncology Fellowship or equivalent training
No more than 6 years post highest degree and 3 years post fellowship
Must not hold a rank higher than Assistant Professor
Must be a U.S. citizen or permanent resident (or valid I-551 status)
Must be employed by a U.S. institution throughout the award period
Must commit at least 50% effort to the CCF-funded research

Funding Details

Total Award: 100,000 USD for one year
Direct costs only — allowable expenses include salary, supplies, and equipment (≤ 5,000 USD)
Indirect costs such as travel, admin fees, memberships, parking, or advertising are not allowed

Key Deadlines

Proposal Submission Deadline: May 4, 2025 by 11:59 PM EST
Notification of Award: August 2025
Award Period: December 2025 – December 2026
Grant Check Presentation: November 1, 2025 at the CCF Gala (Greenbelt, MD)

Award Obligations

Submit a 2–3 page report within 90 days of grant end
Attend the 2025 CCF Gala (Nov 1, 2025)
Participate in the 10th Annual CCF Research Symposium (June 2026)
Acknowledge CCF funding in all publications and presentations

cancer cancer grant funding CCF NextGen Award children's cancer early-career cancer research Giant Food Maryland cancer research OncoDaily Oncology oncology funding opportunity pediatric cancer grant pediatric oncology Young Investigators

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology